Amaxa’s Nucleofector technology is a highly efficient non-viral method for transfection, based on two components: the Nucleofector device that delivers unique electrical parameters and Nucleofector kits that contain cell-type-specific Nucleofector solutions.
The electrical parameters of the Nucleofector are claimed to be different from other electroporation devices. Each electrical setting is displayed as a distinct program which has been adapted to the requirements of a particular cell type. Electrical parameters are preprogrammed into the Nucleofector, thus optimisation by the user is not necessary.
The device weighs 2.6 kg and is sized to fit under a sterile hood, suitable for sterile work with cells.
Phone: 1300 657508
Cayman Chemical Cellular Metabolism Screening Library
Cayman Chemical's Cellular Metabolism Screening Library consists of two plates and contains...
Navinci Diagnostics NaveniFlex Cell Red proximity ligation assay kit
Optimised for cell samples, the kit enables fluorescence visualisation of protein–protein...
Lonza TheraPEAK AmpliCell Cytokines and TheraPEAK 293-GT Medium
The products provide researchers and manufacturers with high-performance, scalable and...
Learn More
I am interested in Amaxa Nucleofector device.
Complete the form and a supplier representative will be in touch.
